![Josiah Craver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josiah Craver
Comptroller/Controller/Auditor bei
FAETH THERAPEUTICS, INC.
Vermögen: - $ am 31.07.2026
Profil
Josiah Craver is Chief Accounting Officer & Senior VP-Finance at Faeth Therapeutics, Inc. starting in 2026.
Former positions include Senior Vice President & Controller at Kala Bio, Inc., and Vice President-Finance at Solid Biosciences, Inc. from 2020.
Education includes undergraduate and graduate degrees from Stonehill College, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.07.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Josiah Craver
| Unternehmen | Position | Beginn |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 17.09.2024 |
Ehemalige bekannte Positionen von Josiah Craver
| Unternehmen | Position | Ende |
|---|---|---|
| SOLID BIOSCIENCES INC. | Comptroller/Controller/Auditor | 01.03.2020 |
| KALA BIO, INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Josiah Craver
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Stonehill College, Inc.
 Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
